Wednesday, June 26, 2019 4:04:17 PM
Thanks for the info but my entire career WAS medicine 
... specifically cardiac- I've got a pretty good handle on most popular drug interactions as well as potential patient reactions. My comments on Viagra were merely anecdotal. In any event, I think you missed my entire point.
The FDA granted approval with recommendations (warranted or not). What I tried to point out was regardless of your support or Feuerstein's condemnation, PTN will rise IF the population (market) wants/needs it, or, fail IF the population (market) refuses to consider or use it. Hyping or bashing the stock is useless at this stage. As in my previous post- which I highlighted and bolded: "The real issue will be whether or not the drug gains any market traction." Getting FDA approval was the goal, which it garnered. Now it must prove itself. PRs and internet chat can't change sales numbers...
... specifically cardiac- I've got a pretty good handle on most popular drug interactions as well as potential patient reactions. My comments on Viagra were merely anecdotal. In any event, I think you missed my entire point. The FDA granted approval with recommendations (warranted or not). What I tried to point out was regardless of your support or Feuerstein's condemnation, PTN will rise IF the population (market) wants/needs it, or, fail IF the population (market) refuses to consider or use it. Hyping or bashing the stock is useless at this stage. As in my previous post- which I highlighted and bolded: "The real issue will be whether or not the drug gains any market traction." Getting FDA approval was the goal, which it garnered. Now it must prove itself. PRs and internet chat can't change sales numbers...
Theo 
;-)
